AstraZeneca wins U.S. FDA approval for 1st-line use of lung cancer drug
April 18, 2018 at 19:58 PM EDT
April 18 (Reuters) - AstraZeneca Plc said on Wednesday the U.S. Food and Drug Administration (FDA) has approved the 1st-line use of its lung cancer drug, Tagrisso.
